Form 4: GoodRx Holdings Executive Romin Nabiey Reports Stock Transactions
SEC Form 4 Filing
Chief Accounting Officer of GoodRx Holdings, Romin Nabiey, reports the vesting and subsequent disposal of Class A Common Stock to cover tax obligations.
Summary
- On May 8, 2024, Romin Nabiey, the Chief Accounting Officer of GoodRx Holdings, Inc., reported transactions involving Class A Common Stock.
- 12,662 shares of Class A Common Stock were acquired through the vesting of restricted stock units.
- Simultaneously, 4,518 shares were disposed of at a price of $7.53 to satisfy tax withholding obligations.
- Following these transactions, Nabiey directly owns 125,817 shares of Class A Common Stock and 151,953 derivative securities (Restricted Stock Units).
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions for tax purposes, and it doesn't indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be an indicator of management's perspective on the company's valuation and future prospects. However, in this case, the sale of shares is explicitly for tax obligations related to vesting, which is a common occurrence.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine stock activity by an executive.
Key Dates
| Date | Description |
|---|---|
| 08/08/2023 | Initial vesting date for 6.25% of the restricted stock units. |
| 05/08/2024 | Date of the reported transactions: vesting of restricted stock units and disposal of shares for tax obligations. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.